| 1 |
37153142 |
Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner |
Mutation
|
| 2 |
37243229 |
Balancing Functional Tradeoffs between Protein Stability and ACE2 Binding in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB Lineages: Dynamics-Based Network Models Reveal Epistatic Effects Modulating Compensatory Dynamic and Energetic Changes |
Mutation
|
| 3 |
37529147 |
Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia |
Mutation
|
| 4 |
39286971 |
SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease |
Mutation
|
| 5 |
39772187 |
Genomic Evolution of the SARS-CoV-2 Omicron Variant in Cordoba, Argentina (2021-2022): Analysis of Uncommon and Prevalent Spike Mutations |
Mutation
|
| 6 |
39881253 |
Unsupervised detection of novel SARS-CoV-2 mutations and lineages in wastewater samples using long-read sequencing |
Mutation
|
| 7 |
36731147 |
Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis |
Mutation
|
| 8 |
36819024 |
Molecular determinants associated with temporal succession of SARS-CoV-2 variants in Uttar Pradesh, India |
Mutation
|
| 9 |
37940989 |
Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron |
Mutation
|
| 10 |
38189279 |
Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects |
Mutation
|
| 11 |
40083630 |
Pilot study: a descriptive-retrospective analysis of SARS-CoV-2 variants distribution and phylogenesis in the Phlegraean area |
Mutation
|
| 12 |
39339934 |
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance |
Mutation
|
| 13 |
40170856 |
Characterizing HLA-A2-restricted CD8(+) T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients |
Mutation
|
| 14 |
35258772 |
Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions |
Mutation
|
| 15 |
39311876 |
Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus |
Mutation
|
| 16 |
33336251 |
Multisystem Inflammatory Syndrome in Children in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2 |
Mutation
|
| 17 |
37796123 |
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics |
Mutation
|
| 18 |
38168680 |
Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection |
Mutation
|
| 19 |
34746689 |
Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern |
Mutation
|
| 20 |
38124756 |
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant |
Mutation
|
| 21 |
35416767 |
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy |
Mutation
|
| 22 |
38421180 |
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection |
Mutation
|
| 23 |
38172120 |
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence |
Mutation
|
| 24 |
36062074 |
The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines |
Mutation
|
| 25 |
35474581 |
T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine |
Mutation
|
| 26 |
38332154 |
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant |
Mutation
|
| 27 |
38365933 |
SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naive mice |
Mutation
|
| 28 |
35496653 |
Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak |
Mutation
|
| 29 |
37651466 |
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo |
Mutation
|
| 30 |
37738983 |
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis |
Mutation
|
| 31 |
38415690 |
Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage |
Mutation
|
| 32 |
36002453 |
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape |
Mutation
|
| 33 |
36320663 |
An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China |
Mutation
|
| 34 |
37306573 |
Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations |
Mutation
|
| 35 |
36985302 |
Development of a Droplet Digital PCR to Monitor SARS-CoV-2 Omicron Variant BA.2 in Wastewater Samples |
Mutation
|
| 36 |
37243152 |
Molecular Epidemiology of SARS-CoV-2 Omicron Sub-Lineages Isolated from Turkish Patients Infected with COVID-19 |
Mutation
|
| 37 |
36474856 |
Distribution of intra-host variations and mutations in the genomes of SARS-CoV-2 and their implications on detection and therapeutics |
Mutation
|
| 38 |
36755883 |
Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India |
Mutation
|
| 39 |
37275159 |
Tracking the first SARS-CoV-2 Omicron BA.5.1.3 outbreak in China |
Mutation
|
| 40 |
35436320 |
Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein |
Mutation
|
| 41 |
37736345 |
Quantification and Differentiation of SARS-CoV-2 Variants in Wastewater for Surveillance |
Mutation
|
| 42 |
37737624 |
Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert |
Mutation
|
| 43 |
37965255 |
Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort |
Mutation
|
| 44 |
38476954 |
Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study |
Mutation
|
| 45 |
37469462 |
Distribution and Functional Analyses of Mutations in Spike Protein and Phylogenic Diversity of SARS-CoV-2 Variants Emerged during the Year 2021 in India |
Mutation
|
| 46 |
38820600 |
Integrated Antigenic and Nucleic Acid Detection in Single Virions and Extracellular Vesicles with Viral Content |
Mutation
|
| 47 |
39405332 |
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection |
Mutation
|
| 48 |
39412285 |
Rapid detection of SARS-CoV-2 variants by molecular-clamping technology-based RT-qPCR |
Mutation
|
| 49 |
40084424 |
Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022 |
Mutation
|
| 50 |
34915551 |
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients |
Mutation
|
| 51 |
34929375 |
Omicron N501Y mutation among SARS-CoV-2 lineages: Insilico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine |
Mutation
|
| 52 |
35016198 |
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 |
Mutation
|
| 53 |
35090164 |
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants |
Mutation
|
| 54 |
35140714 |
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies |
Mutation
|
| 55 |
35321335 |
Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus |
Mutation
|
| 56 |
35336868 |
Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens |
Mutation
|
| 57 |
35474907 |
SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants |
Mutation
|
| 58 |
35597364 |
SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study) |
Mutation
|
| 59 |
36055471 |
Genomic and epidemiologic surveillance of SARS-CoV-2 in Southern Brazil and identification of a new Omicron-L452R sublineage |
Mutation
|
| 60 |
39323472 |
Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India |
Mutation
|
| 61 |
35016194 |
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies |
Mutation
|
| 62 |
35216287 |
Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant |
Mutation
|
| 63 |
35811809 |
Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2 |
Mutation
|
| 64 |
35966763 |
Molecular dynamic simulation suggests stronger interaction of Omicron-spike with ACE2 than wild but weaker than Delta SARS-CoV-2 can be blocked by engineered S1-RBD fraction |
Mutation
|
| 65 |
37631999 |
Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India |
Mutation
|
| 66 |
37894075 |
Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022-2023 |
Mutation
|
| 67 |
37998603 |
Multiplexed RT-qPCR Coupled with Whole-Genome Sequencing to Monitor a SARS-CoV-2 Omicron Variant of Concern in a Hospital Laboratory Setting in Latvia |
Mutation
|
| 68 |
39206813 |
SARS-CoV-2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations |
Mutation
|
| 69 |
39349594 |
Deep learning for discriminating non-trivial conformational changes in molecular dynamics simulations of SARS-CoV-2 spike-ACE2 |
Mutation
|
| 70 |
35336952 |
Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City |
Mutation
|
| 71 |
37477828 |
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants |
Mutation
|
| 72 |
38763300 |
Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study |
Mutation
|
| 73 |
36310647 |
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants |
Mutation
|
| 74 |
38601946 |
Genetic features of SARS-CoV-2 Alpha, Delta, and Omicron variants and their association with the clinical severity of COVID-19 in Vietnam |
Mutation
|
| 75 |
36296228 |
First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco |
Mutation
|
| 76 |
35966675 |
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy |
Mutation
|
| 77 |
35271728 |
Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak |
Mutation
|
| 78 |
38276171 |
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients |
Mutation
|
| 79 |
36423107 |
SARS-CoV-2 Variants of Concern and Variations within Their Genome Architecture: Does Nucleotide Distribution and Mutation Rate Alter the Functionality and Evolution of the Virus? |
Mutation
|
| 80 |
35461811 |
Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants |
Mutation
|
| 81 |
36368287 |
The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between M(pro) and antiviral drugs (nirmatrelvir and ritonavir) |
Mutation
|
| 82 |
39416782 |
M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication |
Mutation
|
| 83 |
35779308 |
Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction |
Mutation
|
| 84 |
39738001 |
Systematic surveillance of SARS-CoV-2 reveals dynamics of variant mutagenesis and transmission in a large urban population |
Mutation
|
| 85 |
35441368 |
Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021 |
Mutation
|
| 86 |
36409091 |
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution |
Mutation
|
| 87 |
36476380 |
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2 |
Mutation
|
| 88 |
36598621 |
A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants |
Mutation
|
| 89 |
36694788 |
Omicron mutations increase interdomain interactions and reduce epitope exposure in the SARS-CoV-2 spike |
Mutation
|
| 90 |
36877050 |
Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants |
Mutation
|
| 91 |
35805724 |
Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan |
Mutation
|
| 92 |
35947606 |
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike |
Mutation
|
| 93 |
38044868 |
Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents |
Mutation
|
| 94 |
39455652 |
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants |
Mutation
|
| 95 |
36840495 |
Viral load of SARS-CoV-2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5 |
Mutation
|
| 96 |
34722330 |
Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity |
Mutation
|
| 97 |
35176774 |
Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection |
Mutation
|
| 98 |
36232627 |
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity |
Mutation
|
| 99 |
34968415 |
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance |
Mutation
|
| 100 |
35461042 |
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization |
Mutation
|
| 101 |
35365787 |
Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile |
Mutation
|
| 102 |
35438777 |
US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell Response |
Mutation
|
| 103 |
34379531 |
Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants |
Mutation
|
| 104 |
33460733 |
TSP-based PCR for rapid identification of L and S type strains of SARS-CoV-2 |
Mutation
|
| 105 |
33391880 |
Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia |
Mutation
|
| 106 |
32895643 |
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020 |
Mutation
|
| 107 |
33508515 |
Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India |
Mutation
|
| 108 |
32699345 |
SARS-CoV-2 genomic variations associated with mortality rate of COVID-19 |
Mutation
|
| 109 |
39310091 |
Deep mutational scanning of SARS-CoV-2 Omicron BA.2.86 and epistatic emergence of the KP.3 variant |
Mutation
|
| 110 |
39259045 |
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages |
Mutation
|
| 111 |
39774959 |
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data |
Mutation
|
| 112 |
40050417 |
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection |
Mutation
|
| 113 |
35464418 |
Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination |
Mutation
|
| 114 |
34578275 |
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q |
Mutation
|
| 115 |
35266815 |
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion |
Mutation
|
| 116 |
36629447 |
Rapid Assessment of SARS-CoV-2 Variant-Associated Mutations in Wastewater Using Real-Time RT-PCR |
Mutation
|
| 117 |
37342350 |
Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform |
Mutation
|
| 118 |
36244851 |
Molecular epidemiology of SARS-CoV-2 in healthcare workers and identification of viral genomic correlates of transmissibility and vaccine break through infection: A retrospective observational study from a cancer hospital in eastern India |
Mutation
|
| 119 |
37684328 |
Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India |
Mutation
|
| 120 |
35062205 |
RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor |
Mutation
|
| 121 |
39863101 |
P3 site-directed mutagenesis: An efficient method based on primer pairs with 3'-overhangs |
Mutation
|
| 122 |
39375326 |
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1 |
Mutation
|
| 123 |
39599801 |
Into the Cauldron of the Variant Soup: Insights into the Molecular Epidemiology and Transition to Endemicity of SARS-CoV-2 in Cyprus (November 2022-February 2024) |
Mutation
|
| 124 |
40001604 |
Epimaps of the SARS-CoV-2 Receptor-Binding Domain Mutational Landscape: Insights into Protein Stability, Epitope Prediction, and Antibody Binding |
Mutation
|
| 125 |
39231977 |
Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants |
Mutation
|
| 126 |
35208920 |
Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect? |
Mutation
|
| 127 |
33093050 |
Coding-Complete Genome Sequences of 23 SARS-CoV-2 Samples from the Philippines |
Mutation
|
| 128 |
39390548 |
The evaluation of SARS-CoV-2 mutations at the early stage of the pandemic in Istanbul population |
Mutation
|
| 129 |
34767598 |
An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms |
Mutation
|
| 130 |
34834948 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Dog in Connecticut in February 2021 |
Mutation
|
| 131 |
33477951 |
Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients |
Mutation
|
| 132 |
35128118 |
SARS-CoV-2 in Egypt: epidemiology, clinical characterization and bioinformatics analysis |
Mutation
|
| 133 |
33900193 |
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China |
Mutation
|
| 134 |
36465857 |
Conformational stability of SARS-CoV-2 glycoprotein spike variants |
Mutation
|
| 135 |
37600458 |
Multiplex Assays Enable Simultaneous Detection and Identification of SARS-CoV-2 Variants of Concern in Clinical and Wastewater Samples |
Mutation
|
| 136 |
35041639 |
A 48-Year-Old Immunocompetent Female Resident of Southern Florida with Confirmed Reinfection with P.1 (Gamma) Variant of SARS-CoV-2 |
Mutation
|
| 137 |
35189404 |
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy |
Mutation
|
| 138 |
39459859 |
Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage |
Mutation
|
| 139 |
34789293 |
Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak |
Mutation
|
| 140 |
38995072 |
MuToN Quantifies Binding Affinity Changes upon Protein Mutations by Geometric Deep Learning |
Mutation
|
| 141 |
39653699 |
A core network in the SARS-CoV-2 nucleocapsid NTD mediates structural integrity and selective RNA-binding |
Mutation
|
| 142 |
36685521 |
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape |
Mutation
|
| 143 |
36006289 |
Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh |
Mutation
|
| 144 |
33875719 |
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology |
Mutation
|
| 145 |
33524589 |
A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity |
Mutation
|
| 146 |
32793182 |
Geographic and Genomic Distribution of SARS-CoV-2 Mutations |
Mutation
|
| 147 |
33075532 |
Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity |
Mutation
|
| 148 |
32478289 |
The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey |
Mutation
|
| 149 |
33306459 |
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay |
Mutation
|
| 150 |
33628442 |
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant |
Mutation
|
| 151 |
33840632 |
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study |
Mutation
|
| 152 |
37092436 |
Whole Sequencing and Detailed Analysis of SARS-CoV-2 Genomes in Southeast Spain: Identification of Recurrent Mutations in the 20E (EU1) Variant with Some Clinical Implications |
Mutation
|
| 153 |
35211985 |
Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India |
Mutation
|
| 154 |
39604453 |
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variants |
Mutation
|
| 155 |
39146693 |
The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study |
Mutation
|
| 156 |
38953636 |
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission |
Mutation
|
| 157 |
40034851 |
Increased pathogenicity and transmissibility in hamsters of all age groups reveal an underestimated perniciousness of severe acute respiratory syndrome coronavirus 2 EG.1 variant |
Mutation
|
| 158 |
39015352 |
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana |
Mutation
|
| 159 |
35578378 |
Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India |
Mutation
|
| 160 |
36197885 |
A RT-qPCR system using a degenerate probe for specific identification and differentiation of SARS-CoV-2 Omicron (B.1.1.529) variants of concern |
Mutation
|
| 161 |
37631058 |
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients |
Mutation
|
| 162 |
39588108 |
Variation and evolution analysis of SARS-CoV-2 using self-game sequence optimization |
Mutation
|
| 163 |
36672914 |
SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region |
Mutation
|
| 164 |
40006937 |
Evaluation of Genomic Surveillance of SARS-CoV-2 Virus Isolates and Comparison of Mutational Spectrum of Variants in Bangladesh |
Mutation
|
| 165 |
39836474 |
The impact of remdesivir on SARS-CoV-2 evolution in vivo |
Mutation
|
| 166 |
37107785 |
Genomic Surveillance of SARS-CoV-2 Variants in the Dominican Republic and Emergence of a Local Lineage |
Mutation
|
| 167 |
36370196 |
Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection |
Mutation
|
| 168 |
40197058 |
Structure and function of an unusual R452-dependent monoclonal antibody against SARS-CoV-2 |
Mutation
|
| 169 |
35071267 |
Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India |
Mutation
|
| 170 |
37367188 |
SARS-CoV CH.1.1 Variant: Genomic and Structural Insight |
Mutation
|
| 171 |
36151403 |
SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope |
Mutation
|
| 172 |
39604601 |
Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021 |
Mutation
|
| 173 |
38435775 |
Comparison of Circulating Variants during the Beginning, Middle and the End of the 4th Wave of COVID-19 in Tehran Province, Iran in 2021 |
Mutation
|
| 174 |
37435034 |
Sequence Analysis of Hot Spot Regions of Spike and RNA-dependent-RNA polymerase (RdRp) Genes of SARS-CoV-2 in Kerman, Iran |
Mutation
|
| 175 |
37301830 |
Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022 |
Mutation
|
| 176 |
37483781 |
The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution |
Mutation
|
| 177 |
34399188 |
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses |
Mutation
|
| 178 |
36405589 |
Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India |
Mutation
|
| 179 |
36846745 |
SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge |
Mutation
|
| 180 |
34835116 |
Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021 |
Mutation
|
| 181 |
37533831 |
Genomic surveillance of genes encoding the SARS-CoV-2 spike protein to monitor for emerging variants on Jeju Island, Republic of Korea |
Mutation
|
| 182 |
36140458 |
SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern |
Mutation
|
| 183 |
36590492 |
The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence |
Mutation
|
| 184 |
36744069 |
Sequence analysis of SARS-CoV-2 Delta variant isolated from Makassar, South Sulawesi, Indonesia |
Mutation
|
| 185 |
37253027 |
SARS-CoV-2 spike protein diversity at an intra-host level, among SARS-CoV-2 infected individuals in South Africa, 2020 to 2022 |
Mutation
|
| 186 |
37350832 |
Isotope-encoded tetrahedral DNA for multiple SARS-CoV-2 variant diagnosis |
Mutation
|
| 187 |
39388246 |
Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method |
Mutation
|
| 188 |
39720734 |
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses |
Mutation
|
| 189 |
39970290 |
Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time |
Mutation
|
| 190 |
35042962 |
Two short low complexity regions (LCRs) are hallmark sequences of the Delta SARS-CoV-2 variant spike protein |
Mutation
|
| 191 |
35458533 |
Functional Analysis of Spike from SARS-CoV-2 Variants Reveals the Role of Distinct Mutations in Neutralization Potential and Viral Infectivity |
Mutation
|
| 192 |
35966679 |
Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity |
Mutation
|
| 193 |
36258215 |
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing |
Mutation
|
| 194 |
36298851 |
Evolutionary Pattern Comparisons of the SARS-CoV-2 Delta Variant in Countries/Regions with High and Low Vaccine Coverage |
Mutation
|
| 195 |
36687433 |
Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania |
Mutation
|
| 196 |
35085490 |
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys |
Mutation
|
| 197 |
34700068 |
Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021 |
Mutation
|
| 198 |
35634532 |
Variation at Spike position 142 in SARS-CoV-2 Delta genomes is a technical artifact caused by dropout of a sequencing amplicon |
Mutation
|
| 199 |
35644262 |
Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern |
Mutation
|
| 200 |
37520374 |
ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus |
Mutation
|
| 201 |
37993530 |
Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing |
Mutation
|
| 202 |
39304686 |
A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2 |
Mutation
|
| 203 |
39719448 |
Structure and dynamics of the interaction of Delta and Omicron BA.1 SARS-CoV-2 variants with REGN10987 Fab reveal mechanism of antibody action |
Mutation
|
| 204 |
34723159 |
Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera |
Mutation
|
| 205 |
34726786 |
Genomic surveillance reveals the detection of SARS-CoV-2 delta, beta, and gamma VOCs during the third wave in Pakistan |
Mutation
|
| 206 |
34823256 |
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation |
Mutation
|
| 207 |
35065253 |
Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India |
Mutation
|
| 208 |
35075065 |
COVID-19 Delta variation; more contagious or more pernicious? |
Mutation
|
| 209 |
35221043 |
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant |
Mutation
|
| 210 |
35285246 |
Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics |
Mutation
|
| 211 |
35337002 |
Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters |
Mutation
|
| 212 |
35412379 |
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants |
Mutation
|
| 213 |
38668234 |
Whole-Genome Sequencing and Mutation Analyses of SARS-CoV-2 Isolates from Indonesia |
Mutation
|
| 214 |
35169135 |
Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies |
Mutation
|
| 215 |
37809129 |
Targeted Sanger Sequencing of a Cluster of COVID-19 Cases in the Surgical ICU of a Non-COVID Hospital: Lessons Learned |
Mutation
|
| 216 |
35759503 |
Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
Mutation
|
| 217 |
37317262 |
Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves |
Mutation
|
| 218 |
36354320 |
Genetic Study of SARS-CoV-2 Non Structural Protein 12 in COVID-19 Patients Non Responders to Remdesivir |
Mutation
|
| 219 |
35156767 |
High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein |
Mutation
|
| 220 |
38133268 |
SARS-CoV-2 Nucleocapsid Protein Mutations Found in Switzerland Disrupt N-Gene Amplification in Commonly Used Multiplex RT-PCR Assay |
Mutation
|
| 221 |
34833991 |
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms |
Mutation
|
| 222 |
35891618 |
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients |
Mutation
|
| 223 |
39339971 |
Combining Short- and Long-Read Sequencing Technologies to Identify SARS-CoV-2 Variants in Wastewater |
Mutation
|
| 224 |
39516586 |
Detection of SARS-CoV-2 in wastewater as an earlier predictor of COVID-19 epidemic peaks in Venezuela |
Mutation
|
| 225 |
35223905 |
Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2 |
Mutation
|
| 226 |
34210893 |
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern |
Mutation
|
| 227 |
33170902 |
Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations |
Mutation
|
| 228 |
35996593 |
Recurrent SARS-CoV-2 mutations in immunodeficient patients |
Mutation
|
| 229 |
36786950 |
Evidence of natural selection and dominance of SARS-CoV-2 variant Lambda (C.37) over variants of concern in Cusco, Peru |
Mutation
|
| 230 |
37243279 |
Molecular Epidemiology of SARS-CoV-2 during Five COVID-19 Waves and the Significance of Low-Frequency Lineages |
Mutation
|
| 231 |
39710752 |
A predictive language model for SARS-CoV-2 evolution |
Mutation
|
| 232 |
40163530 |
Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6 |
Mutation
|
| 233 |
39556615 |
Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting |
Mutation
|
| 234 |
36535326 |
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution |
Mutation
|
| 235 |
36992472 |
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice |
Mutation
|
| 236 |
39840032 |
An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape |
Mutation
|
| 237 |
38605705 |
Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis |
Mutation
|
| 238 |
39548282 |
Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysis |
Mutation
|
| 239 |
35246509 |
Evolution of the SARS-CoV-2 spike protein in the human host |
Mutation
|
| 240 |
38130775 |
Development of primer-probe sets to rapidly distinguish single nucleotide polymorphisms in SARS-CoV-2 lineages |
Mutation
|
| 241 |
35101265 |
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model |
Mutation
|
| 242 |
35047474 |
The Rapid Antigen Detection Test for SARS-CoV-2 Underestimates the Identification of COVID-19 Positive Cases and Compromises the Diagnosis of the SARS-CoV-2 (K417N/T, E484K, and N501Y) Variants |
Mutation
|
| 243 |
34939673 |
Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach |
Mutation
|
| 244 |
37086978 |
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants |
Mutation
|
| 245 |
34705425 |
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle |
Mutation
|
| 246 |
37565759 |
Importance of genomic surveillance of SARS-CoV-2 in cats during reverse zoonosis events: potential viral evolution may occur |
Mutation
|
| 247 |
37355034 |
Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity |
Mutation
|
| 248 |
40005620 |
SARS-CoV-2 XEC: A Genome-Based Survey |
Mutation
|
| 249 |
37178506 |
SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate |
Mutation
|
| 250 |
37460980 |
A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic |
Mutation
|
| 251 |
37058241 |
SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations |
Mutation
|
| 252 |
37744926 |
Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan |
Mutation
|
| 253 |
36560614 |
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges |
Mutation
|
| 254 |
37376693 |
Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing |
Mutation
|
| 255 |
36925722 |
Additional mutations based on Omicron BA.2.75 mediate its further evasion from broadly neutralizing antibodies |
Mutation
|
| 256 |
38332930 |
SARS-CoV-2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID-19 pandemic |
Mutation
|
| 257 |
38003257 |
Comparative Computational Analysis of Spike Protein Structural Stability in SARS-CoV-2 Omicron Subvariants |
Mutation
|
| 258 |
37196370 |
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population |
Mutation
|
| 259 |
36656710 |
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine |
Mutation
|
| 260 |
36366499 |
Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay |
Mutation
|
| 261 |
37626353 |
Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis |
Mutation
|
| 262 |
37892220 |
Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients |
Mutation
|
| 263 |
36992342 |
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents |
Mutation
|
| 264 |
37593745 |
Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera |
Mutation
|
| 265 |
38633395 |
Novel SARS-CoV-2 Omicron variants in Istanbul; Rapid Preponderance of BA.2 and BA.5 |
Mutation
|
| 266 |
37083576 |
Analysis of the ARTIC V4 and V4.1 SARS-CoV-2 primers and their impact on the detection of Omicron BA.1 and BA.2 lineage-defining mutations |
Mutation
|
| 267 |
40121330 |
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants |
Mutation
|
| 268 |
37058198 |
SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants |
Mutation
|
| 269 |
37018136 |
WAVES (Web-based tool for Analysis and Visualization of Environmental Samples)-a web application for visualization of wastewater pathogen sequencing results |
Mutation
|
| 270 |
37163615 |
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine |
Mutation
|
| 271 |
37849762 |
Genome sequencing of SARS-CoV-2 omicron variants in Delhi reveals alterations in immunogenic regions in spike glycoprotein |
Mutation
|
| 272 |
37224159 |
Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2 |
Mutation
|
| 273 |
36992510 |
Molecular Characterization and Cluster Analysis of SARS-CoV-2 Viral Isolates in Kahramanmaras City, Turkey: The Delta VOC Wave within One Month |
Mutation
|
| 274 |
36108630 |
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75 |
Mutation
|
| 275 |
36000843 |
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants |
Mutation
|
| 276 |
37789031 |
Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan |
Mutation
|
| 277 |
39227954 |
Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients |
Mutation
|
| 278 |
36846035 |
SARS-CoV-2 Monitoring on Mink Farms in Poland |
Mutation
|
| 279 |
39660915 |
Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants |
Mutation
|
| 280 |
37511322 |
Impact of E484Q and L452R Mutations on Structure and Binding Behavior of SARS-CoV-2 B.1.617.1 Using Deep Learning AlphaFold2, Molecular Docking and Dynamics Simulation |
Mutation
|
| 281 |
39243518 |
Preventing future zoonosis: SARS-CoV-2 mutations enhance human-animal cross-transmission |
Mutation
|
| 282 |
36211690 |
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants |
Mutation
|
| 283 |
37024459 |
Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection |
Mutation
|
| 284 |
37060743 |
Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance |
Mutation
|
| 285 |
37719318 |
The Single-Nucleotide Polymorphism (SNP) Validity to Detect Omicron Variants |
Mutation
|
| 286 |
37445876 |
A New Method to Detect Variants of SARS-CoV-2 Using Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Bioluminescent Assay in Real Time (RT-LAMP-BART) |
Mutation
|
| 287 |
36988244 |
Identification of SARS CoV-2 Omicron BA.1 and a novel Delta lineage by rapid methods and partial spike protein sequences in Sulaymaniyah Province, Iraq |
Mutation
|
| 288 |
37819267 |
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3 |
Mutation
|
| 289 |
37270625 |
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants |
Mutation
|
| 290 |
36303187 |
Case report: BA.1 subvariant showing a BA.2-like pattern using a variant-specific PCR assay due to a single point mutation downstream the spike 69/70 deletion |
Mutation
|
| 291 |
37200378 |
Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core |
Mutation
|
| 292 |
37120637 |
CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants |
Mutation
|
| 293 |
32474553 |
Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type |
Mutation
|
| 294 |
34631915 |
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan |
Mutation
|
| 295 |
33157300 |
SARS-CoV-2 spread across the Colombian-Venezuelan border |
Mutation
|
| 296 |
34607791 |
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus |
Mutation
|
| 297 |
35778549 |
Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N) circulating in Southern Brazil in 2020 |
Mutation
|
| 298 |
34610919 |
Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada |
Mutation
|
| 299 |
32972948 |
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 |
Mutation
|
| 300 |
33410223 |
A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece |
Mutation
|
| 301 |
33253226 |
SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia |
Mutation
|
| 302 |
34549097 |
Complete genome sequencing and molecular characterization of SARS-COV-2 from COVID-19 cases in Alborz province in Iran |
Mutation
|
| 303 |
34634791 |
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity |
Mutation
|
| 304 |
34960779 |
Role of Q675H Mutation in Improving SARS-CoV-2 Spike Interaction with the Furin Binding Pocket |
Mutation
|
| 305 |
36146842 |
Genomic and Epidemiological Features of COVID-19 in the Novosibirsk Region during the Beginning of the Pandemic |
Mutation
|
| 306 |
38791536 |
Genomic Context of SARS-CoV-2 Outbreaks in Farmed Mink in Spain during Pandemic: Unveiling Host Adaptation Mechanisms |
Mutation
|
| 307 |
33737129 |
Genomic surveillance of SARS-CoV-2 in the Republic of Congo |
Mutation
|
| 308 |
34361977 |
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India |
Mutation
|
| 309 |
35997285 |
Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey |
Mutation
|
| 310 |
34599175 |
Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions |
Mutation
|
| 311 |
35013687 |
Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context |
Mutation
|
| 312 |
35480256 |
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
Mutation
|
| 313 |
34260088 |
SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate? |
Mutation
|
| 314 |
34453338 |
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion |
Mutation
|
| 315 |
35062348 |
Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes |
Mutation
|
| 316 |
35899933 |
Nanomechanical analysis of SARS-CoV-2 variants and predictions of infectiousness and lethality |
Mutation
|
| 317 |
40137759 |
Conformational and Stability Analysis of SARS-CoV-2 Spike Protein Variants by Molecular Simulation |
Mutation
|
| 318 |
40143342 |
Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus |
Mutation
|
| 319 |
35857745 |
Spread of endemic SARS-CoV-2 lineages in Russia before April 2021 |
Mutation
|
| 320 |
37543926 |
Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations |
Mutation
|
| 321 |
35336908 |
In-Flight Transmission of a SARS-CoV-2 Lineage B.1.617.2 Harbouring the Rare S:E484Q Immune Escape Mutation |
Mutation
|
| 322 |
34842496 |
A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain) |
Mutation
|
| 323 |
34886943 |
Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021 |
Mutation
|
| 324 |
34925297 |
Structural Analysis on the Severe Acute Respiratory Syndrome Coronavirus 2 Non-structural Protein 13 Mutants Revealed Altered Bonding Network With TANK Binding Kinase 1 to Evade Host Immune System |
Mutation
|
| 325 |
34735219 |
Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles |
Mutation
|
| 326 |
34499599 |
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy |
Mutation
|
| 327 |
34995777 |
A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY |
Mutation
|
| 328 |
35330908 |
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds |
Mutation
|
| 329 |
37903828 |
Some common deleterious mutations are shared in SARS-CoV-2 genomes from deceased COVID-19 patients across continents |
Mutation
|
| 330 |
34649620 |
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants |
Mutation
|
| 331 |
36305725 |
RPA-ligation-qPCR combined method for genotyping the SARS-CoV-2 key mutation E484Q |
Mutation
|
| 332 |
34679517 |
Rapid Automated Screening for SARS-CoV-2 B.1.617 Lineage Variants (Delta/Kappa) through a Versatile Toolset of qPCR-Based SNP Detection |
Mutation
|
| 333 |
34097716 |
Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan |
Mutation
|
| 334 |
36362871 |
Candidate Multi-Epitope Vaccine against Corona B.1.617 Lineage: In Silico Approach |
Mutation
|
| 335 |
35721780 |
Characterization of mutations modulating enhanced transmissibility of SARS-CoV-2 B.1.617+ (Delta) variant using In Silico tools |
Mutation
|
| 336 |
36034049 |
SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective |
Mutation
|
| 337 |
36062935 |
Variant-specific RT-qPCR for rapid screening of B.1.617 mutations in SARS-CoV-2 |
Mutation
|
| 338 |
34067745 |
An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India |
Mutation
|
| 339 |
34260717 |
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion |
Mutation
|
| 340 |
35296517 |
SARS-CoV-2 spike E156G/Delta157-158 mutations contribute to increased infectivity and immune escape |
Mutation
|
| 341 |
35677879 |
Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding |
Mutation
|
| 342 |
35293847 |
Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity |
Mutation
|
| 343 |
34495709 |
Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021 |
Mutation
|
| 344 |
33896413 |
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications |
Mutation
|
| 345 |
34373458 |
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York |
Mutation
|
| 346 |
33983915 |
Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021 |
Mutation
|
| 347 |
33882219 |
Vaccine Breakthrough Infections with SARS-CoV-2 Variants |
Mutation
|
| 348 |
34607452 |
Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H |
Mutation
|
| 349 |
34309648 |
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination |
Mutation
|
| 350 |
34410361 |
Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals |
Mutation
|
| 351 |
34757638 |
Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021 |
Mutation
|
| 352 |
34764315 |
Emergence of B.1.524(G) SARS-CoV-2 in Malaysia during the third COVID-19 epidemic wave |
Mutation
|
| 353 |
33680867 |
COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang |
Mutation
|
| 354 |
34374354 |
Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay |
Mutation
|
| 355 |
37799539 |
SARS-CoV-2 lineages circulating during the first wave of the pandemic in North Sumatra, Indonesia |
Mutation
|
| 356 |
35458508 |
Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements |
Mutation
|
| 357 |
36504602 |
Possible intraindividual evolution of SARS-CoV-2 in nasopharyngeal and anal swab in an octogenarian: a case report |
Mutation
|
| 358 |
33842902 |
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 |
Mutation
|
| 359 |
34149735 |
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern |
Mutation
|
| 360 |
34171266 |
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
Mutation
|
| 361 |
34037430 |
Multiplex SARS-CoV-2 Genotyping Reverse Transcriptase PCR for Population-Level Variant Screening and Epidemiologic Surveillance |
Mutation
|
| 362 |
34137815 |
Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center |
Mutation
|
| 363 |
34004284 |
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries |
Mutation
|
| 364 |
35183387 |
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals |
Mutation
|
| 365 |
37630656 |
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation |
Mutation
|
| 366 |
34452062 |
The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R |
Mutation
|
| 367 |
33851214 |
Nosocomial Outbreak of Coronavirus Disease 2019 by Possible Airborne Transmission Leading to a Superspreading Event |
Mutation
|
| 368 |
34578382 |
Emergence and Spread of a B.1.1.28-Derived P.6 Lineage with Q675H and Q677H Spike Mutations in Uruguay |
Mutation
|
| 369 |
35243004 |
Importation, circulation, and emergence of variants of SARS-CoV-2 in the South Indian state of Karnataka |
Mutation
|
| 370 |
34409009 |
The Emergence and Spread of Novel SARS-CoV-2 Variants |
Mutation
|
| 371 |
34016042 |
Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil |
Mutation
|
| 372 |
34016740 |
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants |
Mutation
|
| 373 |
34691078 |
Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants |
Mutation
|
| 374 |
34923570 |
Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection |
Mutation
|
| 375 |
34660520 |
The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil |
Mutation
|
| 376 |
33706364 |
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies |
Mutation
|
| 377 |
36224497 |
Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2 |
Mutation
|
| 378 |
33743213 |
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity |
Mutation
|
| 379 |
34188776 |
Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants |
Mutation
|
| 380 |
33605869 |
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil |
Mutation
|
| 381 |
35078012 |
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern |
Mutation
|
| 382 |
35458400 |
Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir |
Mutation
|
| 383 |
33883059 |
Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020 |
Mutation
|
| 384 |
34956222 |
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together |
Mutation
|
| 385 |
33852911 |
Antibody evasion by the P.1 strain of SARS-CoV-2 |
Mutation
|
| 386 |
34730486 |
Insights on the SARS-CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics |
Mutation
|
| 387 |
33684923 |
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 |
Mutation
|
| 388 |
33730597 |
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera |
Mutation
|
| 389 |
34244522 |
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2 |
Mutation
|
| 390 |
34820854 |
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses |
Mutation
|
| 391 |
34428777 |
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York |
Mutation
|
| 392 |
34220870 |
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset |
Mutation
|
| 393 |
35505237 |
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients |
Mutation
|
| 394 |
34058304 |
Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain |
Mutation
|
| 395 |
34448987 |
A SARS-CoV-2 mutant from B.1.258 lineage with delta69/delt70 deletion in the Spike protein circulating in Central Europe in the fall 2020 |
Mutation
|
| 396 |
34545803 |
Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA |
Mutation
|
| 397 |
39390446 |
Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature |
Mutation
|
| 398 |
37692895 |
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual |
Mutation
|
| 399 |
34833135 |
Emerging Mutations Potentially Related to SARS-CoV-2 Immune Escape: The Case of a Long-Term Patient |
Mutation
|
| 400 |
33621484 |
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity |
Mutation
|
| 401 |
34541432 |
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level |
Mutation
|
| 402 |
33531709 |
Sixteen novel lineages of SARS-CoV-2 in South Africa |
Mutation
|
| 403 |
37573409 |
Spike protein mutations and structural insights of pangolin lineage B.1.1.25 with implications for viral pathogenicity and ACE2 binding affinity |
Mutation
|
| 404 |
35196783 |
Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil |
Mutation
|
| 405 |
32937868 |
Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic |
Mutation
|
| 406 |
34689086 |
Emerging SARS-CoV-2 variants expand species tropism to murines |
Mutation
|
| 407 |
40133357 |
Nightlife and low immunity drove transmission of SARS-CoV-2 gamma in Luxembourg, 2021 |
Mutation
|
| 408 |
34668780 |
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice |
Mutation
|
| 409 |
34676574 |
The evaluation of potential global impact of the N501Y mutation in SARS-COV-2 positive patients |
Mutation
|
| 410 |
33728680 |
Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations |
Mutation
|
| 411 |
33755190 |
Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data |
Mutation
|
| 412 |
33549572 |
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir |
Mutation
|
| 413 |
34201088 |
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel |
Mutation
|
| 414 |
33910569 |
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes |
Mutation
|
| 415 |
33806013 |
SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing |
Mutation
|
| 416 |
38624232 |
Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein |
Mutation
|
| 417 |
33803400 |
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications |
Mutation
|
| 418 |
33766552 |
Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan |
Mutation
|
| 419 |
37575355 |
Molecular detection of SARS-CoV-2 in domestic cats in close contact with positively-infected owners in Tehran, Iran in 2021 |
Mutation
|
| 420 |
34385690 |
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function |
Mutation
|
| 421 |
34515998 |
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy |
Mutation
|
| 422 |
33914735 |
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies |
Mutation
|
| 423 |
33969357 |
Structural Consequences of Variation in SARS-CoV-2 B.1.1.7 |
Mutation
|
| 424 |
34081630 |
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern |
Mutation
|
| 425 |
34125658 |
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations |
Mutation
|
| 426 |
34166617 |
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 |
Mutation
|
| 427 |
34254040 |
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates |
Mutation
|
| 428 |
34303698 |
Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences |
Mutation
|
| 429 |
34876033 |
Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report |
Mutation
|
| 430 |
34909610 |
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike |
Mutation
|
| 431 |
34943523 |
Low Represented Mutation Clustering in SARS-CoV-2 B.1.1.7 Sublineage Group with Synonymous Mutations in the E Gene |
Mutation
|
| 432 |
33743891 |
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera |
Mutation
|
| 433 |
35093484 |
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern |
Mutation
|
| 434 |
34424256 |
Emergence of the First Strains of SARS-CoV-2 Lineage B.1.1.7 in Romania: Genomic Analysis |
Mutation
|
| 435 |
35194575 |
SARS-CoV-2 variant B.1.1.7 caused HLA-A2(+) CD8(+) T cell epitope mutations for impaired cellular immune response |
Mutation
|
| 436 |
34678071 |
Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques |
Mutation
|
| 437 |
34044153 |
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay |
Mutation
|
| 438 |
34758391 |
SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance |
Mutation
|
| 439 |
34822776 |
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2 |
Mutation
|
| 440 |
34442817 |
Impact of Full Vaccination with mRNA BNT162b2 on SARS-CoV-2 Infection: Genomic and Subgenomic Viral RNAs Detection in Nasopharyngeal Swab and Saliva of Health Care Workers |
Mutation
|
| 441 |
35283546 |
SARS-CoV-2 infection after vaccination in Italian health care workers: a case report |
Mutation
|
| 442 |
35729053 |
De novo emergence of the mutation E484K in a SARS-CoV-2 B.1.1.7 lineage variant |
Mutation
|
| 443 |
34183681 |
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants |
Mutation
|
| 444 |
34278277 |
SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom |
Mutation
|
| 445 |
34455390 |
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection |
Mutation
|
| 446 |
34877674 |
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multitarget approach |
Mutation
|
| 447 |
34896696 |
Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India |
Mutation
|
| 448 |
37260697 |
Molecular transition of SARS-CoV-2 from critical patients during the first year of the COVID-19 pandemic in Mexico City |
Mutation
|
| 449 |
33951211 |
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K |
Mutation
|
| 450 |
34834987 |
The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City |
Mutation
|
| 451 |
35139811 |
Linked nosocomial COVID-19 outbreak in three facilities for people with intellectual and developmental disabilities due to SARS-CoV-2 variant B.1.1.519 with spike mutation T478K in the Netherlands |
Mutation
|
| 452 |
34086878 |
Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York |
Mutation
|
| 453 |
34742926 |
Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon |
Mutation
|
| 454 |
34358195 |
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants |
Mutation
|
| 455 |
37124420 |
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4(+) T-cell recognition in an agammaglobulinemia patient |
Mutation
|
| 456 |
35079088 |
Pro108Ser mutation of SARS-CoV-2 3CL(pro) reduces the enzyme activity and ameliorates the clinical severity of COVID-19 |
Mutation
|
| 457 |
34451453 |
Predominance of the SARS-CoV-2 Lineage P.1 and Its Sublineage P.1.2 in Patients from the Metropolitan Region of Porto Alegre, Southern Brazil in March 2021 |
Mutation
|
| 458 |
34583340 |
Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study |
Mutation
|
| 459 |
34492088 |
Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination |
Mutation
|
| 460 |
34314050 |
SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021 |
Mutation
|
| 461 |
34272947 |
An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern |
Mutation
|
| 462 |
33664494 |
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies |
Mutation
|
| 463 |
36778569 |
A SARS-CoV-2 full genome sequence of the B.1.1 lineage sheds light on viral evolution in Sicily in late 2020 |
Mutation
|
| 464 |
33201914 |
Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam |
Mutation
|
| 465 |
33853970 |
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil |
Mutation
|
| 466 |
34834984 |
Macrophages and Monocytes: "Trojan Horses" in COVID-19 |
Mutation
|
| 467 |
36029839 |
Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy |
Mutation
|
| 468 |
38140677 |
Epidemiologic and Genomic Evidence for Zoonotic Transmission of SARS-CoV-2 among People and Animals on a Michigan Mink Farm, United States, 2020 |
Mutation
|
| 469 |
33468702 |
SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia |
Mutation
|
| 470 |
36000850 |
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection |
Mutation
|
| 471 |
35661577 |
Clinical and virologic factors associated with outcomes of COVID-19 before and after vaccination among Veterans: Retrospective analysis from six New England states |
Mutation
|
| 472 |
33275900 |
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
Mutation
|
| 473 |
33441410 |
An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa |
Mutation
|
| 474 |
33738124 |
SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity |
Mutation
|
| 475 |
33798491 |
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant |
Mutation
|
| 476 |
35014989 |
COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis |
Mutation
|
| 477 |
33072699 |
Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile |
Mutation
|
| 478 |
34452511 |
Monitoring SARS-CoV-2 Populations in Wastewater by Amplicon Sequencing and Using the Novel Program SAM Refiner |
Mutation
|
| 479 |
35577569 |
Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant |
Mutation
|
| 480 |
33259879 |
Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences |
Mutation
|
| 481 |
32823907 |
Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic |
Mutation
|
| 482 |
32641486 |
Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico |
Mutation
|
| 483 |
35215992 |
Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes |
Mutation
|
| 484 |
35060147 |
SARS-CoV-2 intralineage variation and temporal patterns of COVID-19 risk factors in three cities of southeastern Brazil: Age, sex, and race |
Mutation
|
| 485 |
35171035 |
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil |
Mutation
|
| 486 |
38565881 |
SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand |
Mutation
|
| 487 |
36560738 |
Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63 |
Mutation
|
| 488 |
35229308 |
SARS-COV-2 genomic monitoring in the state of Sao Paulo unveils two emerging AY.43 sublineages |
Mutation
|
| 489 |
34766651 |
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight |
Mutation
|
| 490 |
35290827 |
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 |
Mutation
|
| 491 |
35992703 |
Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games |
Mutation
|
| 492 |
34753092 |
RT-qPCR assays for SARS-CoV-2 variants of concern in wastewater reveals compromised vaccination-induced immunity |
Mutation
|
| 493 |
34794434 |
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021 |
Mutation
|
| 494 |
36315517 |
One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021 |
Mutation
|
| 495 |
35371558 |
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia |
Mutation
|
| 496 |
35597249 |
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study |
Mutation
|
| 497 |
37520539 |
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5 |
Mutation
|
| 498 |
35605880 |
Lebanese SARS-CoV-2 genomics: 24 months of the pandemic |
Mutation
|
| 499 |
36125289 |
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy |
Mutation
|
| 500 |
36688179 |
Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: an epidemiological surveillance assessment |
Mutation
|
| 501 |
34821555 |
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice |
Mutation
|
| 502 |
35130727 |
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021 |
Mutation
|
| 503 |
39339912 |
SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape |
Mutation
|
| 504 |
37105480 |
Identification of SARS-CoV-2 variants in wastewater using targeted amplicon sequencing during a low COVID-19 prevalence period in Japan |
Mutation
|
| 505 |
36400646 |
Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India |
Mutation
|
| 506 |
34818667 |
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission |
Mutation
|
| 507 |
35056592 |
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression |
Mutation
|
| 508 |
35718540 |
SARS-CoV-2 whole-proteome sequences from environment as an indicator of community viral distribution, evolution and epidemiological dynamics: A cohort analysis of Austria |
Mutation
|
| 509 |
35285705 |
Specific Detection of SARS-CoV-2 Variants B.1.1.7 (Alpha) and B.1.617.2 (Delta) Using a One-Step Quantitative PCR Assay |
Mutation
|
| 510 |
35181735 |
Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module |
Mutation
|
| 511 |
36438919 |
Comparison of Clinical Characteristics and Outcomes of Hospitalized Patients Infected with the D614G Strain or Alpha Variant of COVID-19 in Taiwan: A Multi-Center Cohort Study |
Mutation
|
| 512 |
33558493 |
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity |
Mutation
|
| 513 |
32701194 |
Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia |
Mutation
|
| 514 |
34452356 |
Rise and Fall of SARS-CoV-2 Lineage A.27 in Germany |
Mutation
|
| 515 |
35241661 |
Antibody escape and global spread of SARS-CoV-2 lineage A.27 |
Mutation
|
| 516 |
35095814 |
A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands |
Mutation
|
| 517 |
34107326 |
SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama |
Mutation
|
| 518 |
33735608 |
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape |
Mutation
|
| 519 |
33690265 |
Detection of a SARS-CoV-2 variant of concern in South Africa |
Mutation
|
| 520 |
33780970 |
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma |
Mutation
|
| 521 |
34021265 |
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines |
Mutation
|
| 522 |
33413740 |
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 |
Mutation
|
| 523 |
33920487 |
Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective |
Mutation
|
| 524 |
39392000 |
Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020 |
Mutation
|
| 525 |
34880295 |
Emergence of novel combinations of SARS-CoV-2 spike receptor binding domain variants in Senegal |
Mutation
|
| 526 |
34042186 |
Genome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: Understanding the nature of the epidemic and role of the D614G mutation |
Mutation
|
| 527 |
34095334 |
High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19 |
Mutation
|
| 528 |
38793600 |
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019 |
Mutation
|
| 529 |
34547443 |
Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution |
Mutation
|
| 530 |
32764372 |
Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory |
Mutation
|
| 531 |
34319130 |
Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma |
Mutation
|
| 532 |
33572190 |
Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging |
Mutation
|
| 533 |
33131453 |
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal |
Mutation
|
| 534 |
33127745 |
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain |
Mutation
|
| 535 |
35105893 |
SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load |
Mutation
|
| 536 |
33329480 |
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity |
Mutation
|
| 537 |
34540874 |
Whole Genome Sequencing of SARS-CoV-2 Strains in COVID-19 Patients From Djibouti Shows Novel Mutations and Clades Replacing Over Time |
Mutation
|
| 538 |
35150193 |
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab |
Mutation
|
| 539 |
38125422 |
Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China |
Mutation
|
| 540 |
39156763 |
XBB.1.16-RBD-based trimeric protein vaccine can effectively inhibit XBB.1.16-included XBB subvariant infection |
Mutation
|
| 541 |
32357545 |
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment |
Mutation
|
| 542 |
32697968 |
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus |
Mutation
|
| 543 |
32697970 |
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear |
Mutation
|
| 544 |
32732280 |
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy |
Mutation
|
| 545 |
38527669 |
COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years |
Mutation
|
| 546 |
38076717 |
Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India - a cohort study |
Mutation
|
| 547 |
32422894 |
A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity? |
Mutation
|
| 548 |
32742035 |
Variant analysis of SARS-CoV-2 genomes |
Mutation
|
| 549 |
32464271 |
Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality? |
Mutation
|
| 550 |
32543353 |
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East |
Mutation
|
| 551 |
38879684 |
Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production |
Mutation
|
| 552 |
38543708 |
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis |
Mutation
|
| 553 |
32693089 |
Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants |
Mutation
|
| 554 |
36949118 |
Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India |
Mutation
|
| 555 |
36974160 |
Molecular evolutionary model based on phylogenetic and mutation analysis of SARS-CoV-2 spike protein sequences from Asian countries: A phylogenomic approach |
Mutation
|
| 556 |
37064465 |
Structural insights into the effect of mutations in the spike protein of SARS-CoV-2 on the binding with human furin protein |
Mutation
|
| 557 |
37059256 |
Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021 |
Mutation
|
| 558 |
36986360 |
Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation |
Mutation
|
| 559 |
38319081 |
A photocontrolled one-pot isothermal amplification and CRISPR-Cas12a assay for rapid detection of SARS-CoV-2 Omicron variants |
Mutation
|
| 560 |
39937661 |
AnnCovDB: a manually curated annotation database for mutations in SARS-CoV-2 spike protein |
Mutation
|
| 561 |
32839745 |
miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East |
Mutation
|
| 562 |
33015402 |
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR(-/-) mice |
Mutation
|
| 563 |
33380328 |
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants |
Mutation
|
| 564 |
33431822 |
Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein |
Mutation
|
| 565 |
33567580 |
In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface |
Mutation
|
| 566 |
33649290 |
D614G and SARS-CoV-2 replication fitness |
Mutation
|
| 567 |
33900399 |
Genomic Epidemiology of SARS-CoV-2 Infection During the Initial Pandemic Wave and Association With Disease Severity |
Mutation
|
| 568 |
33941621 |
Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State |
Mutation
|
| 569 |
33991677 |
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage |
Mutation
|
| 570 |
34157472 |
Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection |
Mutation
|
| 571 |
36008511 |
SARS-CoV-2 genome variations and evolution patterns in Egypt: a multi-center study |
Mutation
|
| 572 |
36016784 |
The SARS-CoV-2 differential genomic adaptation in response to varying UVindex reveals potential genomic resources for better COVID-19 diagnosis and prevention |
Mutation
|
| 573 |
36041637 |
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength? |
Mutation
|
| 574 |
36060458 |
Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2 |
Mutation
|
| 575 |
36069551 |
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection |
Mutation
|
| 576 |
36184693 |
An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2 |
Mutation
|
| 577 |
36189631 |
Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients |
Mutation
|
| 578 |
36333340 |
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding |
Mutation
|
| 579 |
36610932 |
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants |
Mutation
|
| 580 |
36625603 |
Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations |
Mutation
|
| 581 |
36644321 |
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals |
Mutation
|
| 582 |
36733340 |
Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity |
Mutation
|
| 583 |
36751428 |
Evolutionary rate of SARS-CoV-2 increases during zoonotic infection of farmed mink |
Mutation
|
| 584 |
36786605 |
Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants |
Mutation
|
| 585 |
36799841 |
The D614G mutation helps to increase the transmissibility and reduce the virulence of SARS-CoV-2 variants through natural selection |
Mutation
|
| 586 |
36841805 |
Global landscape of SARS-CoV-2 mutations and conserved regions |
Mutation
|
| 587 |
36877070 |
A Rapid Method for Generating Infectious SARS-CoV-2 and Variants Using Mutagenesis and Circular Polymerase Extension Cloning |
Mutation
|
| 588 |
36915185 |
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection |
Mutation
|
| 589 |
32884216 |
Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development |
Mutation
|
| 590 |
32972934 |
Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh |
Mutation
|
| 591 |
33049387 |
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants |
Mutation
|
| 592 |
33384909 |
Mutational spectra of SARS-CoV-2 isolated from animals |
Mutation
|
| 593 |
33766711 |
SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin |
Mutation
|
| 594 |
36998522 |
The influence of single-point mutation D614G on the binding process between human angiotensin-converting enzyme 2 and the SARS-CoV-2 spike protein-an atomistic simulation study |
Mutation
|
| 595 |
37126534 |
Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike |
Mutation
|
| 596 |
37244245 |
A polyethylene glycol enhanced ligation-triggered self-priming isothermal amplification for the detection of SARS-CoV-2 D614G mutation |
Mutation
|
| 597 |
37595664 |
Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran |
Mutation
|
| 598 |
38364100 |
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients |
Mutation
|
| 599 |
37564431 |
Comparative Analysis and Identification of Spike Mutations in Iranian COVID-19 Samples from the First Three Waves of Disease |
Mutation
|
| 600 |
39294134 |
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections |
Mutation
|
| 601 |
39459877 |
Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study |
Mutation
|
| 602 |
39459941 |
Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India |
Mutation
|
| 603 |
39720788 |
Emergence of Omicron FN.1 a descendent of BQ.1.1 in Botswana |
Mutation
|
| 604 |
39770311 |
Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq |
Mutation
|
| 605 |
39859459 |
Ultra-Sensitive Aptamer-Based Diagnostic Systems for Rapid Detection of All SARS-CoV-2 Variants |
Mutation
|
| 606 |
39861827 |
Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes |
Mutation
|
| 607 |
40063870 |
SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India |
Mutation
|
| 608 |
40082784 |
SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy |
Mutation
|
| 609 |
40124365 |
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19 |
Mutation
|
| 610 |
40160532 |
Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients |
Mutation
|
| 611 |
40326760 |
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population |
Mutation
|
| 612 |
37334976 |
SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients |
Mutation
|
| 613 |
37475040 |
Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity |
Mutation
|
| 614 |
32779780 |
Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2 |
Mutation
|
| 615 |
32820179 |
Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide |
Mutation
|
| 616 |
32868447 |
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants |
Mutation
|
| 617 |
32905045 |
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant |
Mutation
|
| 618 |
32934770 |
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity |
Mutation
|
| 619 |
32941419 |
Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization |
Mutation
|
| 620 |
33049069 |
Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis |
Mutation
|
| 621 |
33067385 |
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals |
Mutation
|
| 622 |
33083031 |
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein |
Mutation
|
| 623 |
33113345 |
High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States |
Mutation
|
| 624 |
33184173 |
Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations |
Mutation
|
| 625 |
33184236 |
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo |
Mutation
|
| 626 |
33208827 |
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 |
Mutation
|
| 627 |
33412089 |
COVID-19-neutralizing antibodies predict disease severity and survival |
Mutation
|
| 628 |
33458832 |
World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype |
Mutation
|
| 629 |
33468695 |
SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike |
Mutation
|
| 630 |
33502471 |
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series |
Mutation
|
| 631 |
33560990 |
In Silico Prediction of New Mutations That Can Improve the Binding Abilities Between 2019-nCoV Coronavirus and Human ACE2 |
Mutation
|
| 632 |
33649299 |
Mutation D614G increases SARS-CoV-2 transmission |
Mutation
|
| 633 |
33725432 |
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant |
Mutation
|
| 634 |
33727252 |
Structural impact on SARS-CoV-2 spike protein by D614G substitution |
Mutation
|
| 635 |
33760807 |
SARS-CoV-2 variants reveal features critical for replication in primary human cells |
Mutation
|
| 636 |
33893880 |
Combined RT-qPCR and pyrosequencing of a Spike glycoprotein polybasic cleavage motif can uncover pediatric SARS-CoV-2 infections associated with heterogeneous presentation |
Mutation
|
| 637 |
33906967 |
Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9 |
Mutation
|
| 638 |
33926459 |
A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions |
Mutation
|
| 639 |
34637549 |
Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro |
Mutation
|
| 640 |
36145442 |
Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes |
Mutation
|
| 641 |
32763945 |
Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology |
Mutation
|
| 642 |
32780783 |
Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2 |
Mutation
|
| 643 |
32881907 |
Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight |
Mutation
|
| 644 |
33163249 |
The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene |
Mutation
|
| 645 |
33185784 |
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment |
Mutation
|
| 646 |
33374416 |
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation |
Mutation
|
| 647 |
33412760 |
Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19 |
Mutation
|
| 648 |
33662015 |
Genomic characterization and evolution of SARS-CoV-2 of a Canadian population |
Mutation
|
| 649 |
34267528 |
Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan |
Mutation
|
| 650 |
34463219 |
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein |
Mutation
|
| 651 |
39847599 |
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques |
Mutation
|
| 652 |
36560780 |
Multiple Mutations Associated with Emergent Variants Can Be Detected as Low-Frequency Mutations in Early SARS-CoV-2 Pandemic Clinical Samples |
Mutation
|
| 653 |
36362544 |
Association of Clinical Features with Spike Glycoprotein Mutations in Iranian COVID-19 Patients |
Mutation
|
| 654 |
34817202 |
Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein |
Mutation
|
| 655 |
37292282 |
Identification of conserved linear epitopes in the SARS-CoV-2 receptor-binding region using monoclonal antibodies |
Mutation
|
| 656 |
34433803 |
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker |
Mutation
|
| 657 |
40153503 |
Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape |
Mutation
|
| 658 |
33667349 |
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients |
Mutation
|
| 659 |
39746041 |
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies |
Mutation
|
| 660 |
39903775 |
Reaction Pathway Differentiation Enabled Fingerprinting Signal for Single Nucleotide Variant Detection |
Mutation
|
| 661 |
40281619 |
SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individuals |
Mutation
|
| 662 |
33778179 |
Mutational analysis of structural proteins of SARS-CoV-2 |
Mutation
|
| 663 |
33788923 |
Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco |
Mutation
|
| 664 |
33929934 |
A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter |
Mutation
|
| 665 |
33993052 |
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice |
Mutation
|
| 666 |
34245452 |
Updated SARS-CoV-2 single nucleotide variants and mortality association |
Mutation
|
| 667 |
34423763 |
Severe Acute Respiratory Syndrome Coronavirus 2 in Farmed Mink (Neovison vison), Poland |
Mutation
|
| 668 |
34535691 |
Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020 |
Mutation
|
| 669 |
34683466 |
SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort |
Mutation
|
| 670 |
34780574 |
Infection, recovery and re-infection of farmed mink with SARS-CoV-2 |
Mutation
|
| 671 |
34920116 |
Zoonotic spill-over of SARS-CoV-2: mink-adapted virus in humans |
Mutation
|
| 672 |
34966387 |
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants |
Mutation
|
| 673 |
34979405 |
Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study |
Mutation
|
| 674 |
35004593 |
Analysis of Clinical Characteristics and Virus Strains Variation of Patients Infected With SARS-CoV-2 in Jiangsu Province-A Retrospective Study |
Mutation
|
| 675 |
35093235 |
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway |
Mutation
|
| 676 |
35215919 |
Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines |
Mutation
|
| 677 |
35323111 |
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike |
Mutation
|
| 678 |
35370361 |
CRISPR-Cas13a cascade-based viral RNA assay for detecting SARS-CoV-2 and its mutations in clinical samples |
Mutation
|
| 679 |
35397208 |
Dynamic Ca(2+) sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry |
Mutation
|
| 680 |
35399374 |
Unique peptide signatures of SARS-ComicronV-2 virus against human proteome reveal variants' immune escape and infectiveness |
Mutation
|
| 681 |
35421842 |
Split T7 promoter-based isothermal transcription amplification for one-step fluorescence detection of SARS-CoV-2 and emerging variants |
Mutation
|
| 682 |
35489692 |
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge |
Mutation
|
| 683 |
35494175 |
Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants |
Mutation
|
| 684 |
32975856 |
Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations |
Mutation
|
| 685 |
36016239 |
Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus |
Mutation
|
| 686 |
36016943 |
Protective antigenic epitopes revealed by immunosignatures after three doses of inactivated SARS-CoV-2 vaccine |
Mutation
|
| 687 |
36090111 |
Molecular epidemiology and genetic characterization of SARS-CoV-2 in Kuwait: A descriptive study |
Mutation
|
| 688 |
36301637 |
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity |
Mutation
|
| 689 |
36315931 |
High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2 |
Mutation
|
| 690 |
36409093 |
Tracing the First Days of the SARS-CoV-2 Pandemic in Greece and the Role of the First Imported Group of Travelers |
Mutation
|
| 691 |
36428893 |
Fluorescence-Linked Aptamer Assay for SARS-CoV-2 Spike-Protein: A Step-by-Step Performance Analysis in Clinical Samples |
Mutation
|
| 692 |
36460750 |
Neutrophils play a major role in the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters |
Mutation
|
| 693 |
36528612 |
Mutations in SARS-CoV-2 structural proteins: a global analysis |
Mutation
|
| 694 |
36845100 |
Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation |
Mutation
|
| 695 |
36519597 |
Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization |
Mutation
|
| 696 |
34987509 |
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection |
Mutation
|
| 697 |
34595399 |
Genomic epidemiological analysis of SARS-CoV-2 household transmission |
Mutation
|
| 698 |
35029751 |
Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein |
Mutation
|
| 699 |
35042653 |
Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2 |
Mutation
|
| 700 |
35538682 |
Phylogenetic and genome-wide mutational analysis of SARS-CoV-2 strains circulating in Nigeria: no implications for attenuated COVID-19 outcomes |
Mutation
|
| 701 |
35552003 |
Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia |
Mutation
|
| 702 |
35614572 |
Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts |
Mutation
|
| 703 |
35707000 |
Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins |
Mutation
|
| 704 |
35707124 |
Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia |
Mutation
|
| 705 |
35761832 |
Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays |
Mutation
|
| 706 |
35772213 |
SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors |
Mutation
|
| 707 |
35792936 |
The Impact of D614G Mutation of SARS-COV-2 on the Efficacy of Anti-viral Drugs: A Comparative Molecular Docking and Molecular Dynamics Study |
Mutation
|
| 708 |
35899968 |
De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients |
Mutation
|
| 709 |
35905853 |
Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States |
Mutation
|
| 710 |
35913920 |
Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019-2022 |
Mutation
|
| 711 |
33301503 |
CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention |
Mutation
|
| 712 |
34466655 |
Furin and the adaptive mutation of SARS-COV2: a computational framework |
Mutation
|
| 713 |
38003792 |
Genomic Mutations in SARS-CoV-2 Genome following Infection in Syrian Golden Hamster and Associated Lung Pathologies |
Mutation
|
| 714 |
38348230 |
Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient |
Mutation
|
| 715 |
38204428 |
Genetic diversity and evolutionary patterns of SARS-CoV-2 among the Bhutanese population during the pandemic |
Mutation
|
| 716 |
36474565 |
In silico analysis of the substitution mutations and evolutionary trends of the SARS-CoV-2 structural proteins in Asia |
Mutation
|
| 717 |
36938325 |
The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants |
Mutation
|
| 718 |
36057416 |
Genomic surveillance: Circulating lineages and genomic variation of SARS-CoV-2 in early pandemic in Ceara state, Northeast Brazil |
Mutation
|
| 719 |
32300673 |
Genomic characterization of a novel SARS-CoV-2 |
Mutation
|
| 720 |
39489759 |
Genomic surveillance of Canadian airport wastewater samples allows early detection of emerging SARS-CoV-2 lineages |
Mutation
|
| 721 |
40130852 |
The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19 |
Mutation
|
| 722 |
40302923 |
SARS-COV-2 causes significant abnormalities in the fibrinolysis system of patients: correlation between viral mutations, variants and thrombosis |
Mutation
|
| 723 |
32964802 |
Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms |
Mutation
|
| 724 |
33106671 |
Spike mutation D614G alters SARS-CoV-2 fitness |
Mutation
|
| 725 |
33144203 |
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain |
Mutation
|
| 726 |
33219681 |
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019 |
Mutation
|
| 727 |
33306985 |
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization |
Mutation
|
| 728 |
33310888 |
Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects |
Mutation
|
| 729 |
33347622 |
Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity |
Mutation
|
| 730 |
33408342 |
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity |
Mutation
|
| 731 |
33478625 |
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020 |
Mutation
|
| 732 |
33495741 |
Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa |
Mutation
|
| 733 |
33503420 |
The immunodominant and neutralization linear epitopes for SARS-CoV-2 |
Mutation
|
| 734 |
33506644 |
Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease |
Mutation
|
| 735 |
33535027 |
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization |
Mutation
|
| 736 |
33545711 |
SARS-CoV-2 evolution during treatment of chronic infection |
Mutation
|
| 737 |
33558724 |
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera |
Mutation
|
| 738 |
33558859 |
Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco |
Mutation
|
| 739 |
33570490 |
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types |
Mutation
|
| 740 |
33579701 |
Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile |
Mutation
|
| 741 |
33580132 |
Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada |
Mutation
|
| 742 |
33580783 |
Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2 |
Mutation
|
| 743 |
33622851 |
Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2 |
Mutation
|
| 744 |
33633229 |
Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population |
Mutation
|
| 745 |
33636719 |
SARS-CoV-2 spike D614G change enhances replication and transmission |
Mutation
|
| 746 |
33671631 |
Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants |
Mutation
|
| 747 |
33692211 |
SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia |
Mutation
|
| 748 |
33716040 |
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization |
Mutation
|
| 749 |
33738620 |
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran |
Mutation
|
| 750 |
33738989 |
Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2 |
Mutation
|
| 751 |
33750399 |
Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example |
Mutation
|
| 752 |
33758785 |
Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein |
Mutation
|
| 753 |
33767200 |
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization |
Mutation
|
| 754 |
33772244 |
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies |
Mutation
|
| 755 |
33785459 |
Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant |
Mutation
|
| 756 |
33789085 |
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera |
Mutation
|
| 757 |
33789940 |
Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage |
Mutation
|
| 758 |
33835709 |
SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions |
Mutation
|
| 759 |
33863729 |
The SARS-CoV-2 Spike variant D614G favors an open conformational state |
Mutation
|
| 760 |
33886690 |
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways |
Mutation
|
| 761 |
33932525 |
Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes |
Mutation
|
| 762 |
33976134 |
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes |
Mutation
|
| 763 |
34044152 |
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France |
Mutation
|
| 764 |
34064904 |
Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike's Dynamics |
Mutation
|
| 765 |
34105996 |
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity |
Mutation
|
| 766 |
34140350 |
Characterization of a new SARS-CoV-2 variant that emerged in Brazil |
Mutation
|
| 767 |
34161095 |
Allosteric Cross-Talk among Spike's Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor |
Mutation
|
| 768 |
34184982 |
Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management |
Mutation
|
| 769 |
34210996 |
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
Mutation
|
| 770 |
34248922 |
In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms |
Mutation
|
| 771 |
34262921 |
Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K |
Mutation
|
| 772 |
34271250 |
Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas |
Mutation
|
| 773 |
34312390 |
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants |
Mutation
|
| 774 |
34314668 |
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19 |
Mutation
|
| 775 |
34315826 |
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models |
Mutation
|
| 776 |
34333122 |
SARS-CoV-2 in Transit: Characterization of SARS-CoV-2 Genomes From Venezuelan Migrants in Colombia |
Mutation
|
| 777 |
34352039 |
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies |
Mutation
|
| 778 |
34354142 |
Entropy based analysis of SARS-CoV-2 spread in India using informative subtype markers |
Mutation
|
| 779 |
34372500 |
Molecular Evolution and Epidemiological Characteristics of SARS COV-2 in (Northwestern) Poland |
Mutation
|
| 780 |
34414185 |
N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation |
Mutation
|
| 781 |
34419160 |
Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein |
Mutation
|
| 782 |
34419925 |
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum |
Mutation
|
| 783 |
34431691 |
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment |
Mutation
|
| 784 |
34452507 |
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2 |
Mutation
|
| 785 |
34454120 |
The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study |
Mutation
|
| 786 |
34460119 |
Neutralization of alpha, gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies |
Mutation
|
| 787 |
34473242 |
Association of E484K Spike Protein Mutation With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Persons: Maryland, January-May 2021 |
Mutation
|
| 788 |
34484190 |
Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies |
Mutation
|
| 789 |
34518554 |
Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India |
Mutation
|
| 790 |
34533304 |
The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia |
Mutation
|
| 791 |
34537363 |
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies |
Mutation
|
| 792 |
34539645 |
Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 |
Mutation
|
| 793 |
34549975 |
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants |
Mutation
|
| 794 |
34553217 |
Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations |
Mutation
|
| 795 |
34563540 |
D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation |
Mutation
|
| 796 |
34578363 |
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India |
Mutation
|
| 797 |
34613786 |
Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition |
Mutation
|
| 798 |
34615860 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil |
Mutation
|
| 799 |
34634289 |
SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement |
Mutation
|
| 800 |
34648735 |
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential |
Mutation
|
| 801 |
34693968 |
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins |
Mutation
|
| 802 |
34700382 |
Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using in Silico Approach |
Mutation
|
| 803 |
34725366 |
Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations |
Mutation
|
| 804 |
34733263 |
Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission |
Mutation
|
| 805 |
34741079 |
Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations |
Mutation
|
| 806 |
34748603 |
Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption |
Mutation
|
| 807 |
34785663 |
Organ-specific genome diversity of replication-competent SARS-CoV-2 |
Mutation
|
| 808 |
34805715 |
Mutation-Induced Long-Range Allosteric Interactions in the Spike Protein Determine the Infectivity of SARS-CoV-2 Emerging Variants |
Mutation
|
| 809 |
34818119 |
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination |
Mutation
|
| 810 |
34834983 |
High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2 |
Mutation
|
| 811 |
34846283 |
Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms |
Mutation
|
| 812 |
34873910 |
Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America |
Mutation
|
| 813 |
34877393 |
Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera |
Mutation
|
| 814 |
34886945 |
Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020 |
Mutation
|
| 815 |
34890524 |
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron |
Mutation
|
| 816 |
34907182 |
Estimating the strength of selection for new SARS-CoV-2 variants |
Mutation
|
| 817 |
34943191 |
A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19 |
Mutation
|
| 818 |
34968862 |
Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches |
Mutation
|
| 819 |
34993157 |
Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India |
Mutation
|
| 820 |
35007661 |
A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: Effects on proteolytic cleavage and ACE2 binding |
Mutation
|
| 821 |
35012335 |
Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor |
Mutation
|
| 822 |
35020754 |
SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection |
Mutation
|
| 823 |
35056548 |
Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan |
Mutation
|
| 824 |
35062281 |
Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys) |
Mutation
|
| 825 |
35066015 |
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters |
Mutation
|
| 826 |
35095827 |
Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia |
Mutation
|
| 827 |
35096288 |
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects |
Mutation
|
| 828 |
35133792 |
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants |
Mutation
|
| 829 |
35215820 |
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies |
Mutation
|
| 830 |
35216664 |
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses |
Mutation
|
| 831 |
35233173 |
In-silico genomic landscape characterization and evolution of SARS-CoV-2 variants isolated in India shows significant drift with high frequency of mutations |
Mutation
|
| 832 |
35307848 |
Low-frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled-edged sword |
Mutation
|
| 833 |
35308337 |
Emergence of Progressive Mutations in SARS-CoV-2 From a Hematologic Patient With Prolonged Viral Replication |
Mutation
|
| 834 |
35308382 |
Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations? |
Mutation
|
| 835 |
35336187 |
Circulation of SARS-CoV-2 Variants among Children from November 2020 to January 2022 in Trieste (Italy) |
Mutation
|
| 836 |
35336922 |
Multiorgan and Vascular Tropism of SARS-CoV-2 |
Mutation
|
| 837 |
35369437 |
Mutations and Phylogenetic Analyses of SARS-CoV-2 Among Imported COVID-19 From Abroad in Nanjing, China |
Mutation
|
| 838 |
35371108 |
Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization |
Mutation
|
| 839 |
35380448 |
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies |
Mutation
|
| 840 |
35401825 |
Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination |
Mutation
|
| 841 |
35419205 |
Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution |
Mutation
|
| 842 |
35434713 |
Antigenicity comparison of SARS-CoV-2 Omicron sublineages with other variants contained multiple mutations in RBD |
Mutation
|
| 843 |
35434714 |
Characteristic analysis of Omicron-included SARS-CoV-2 variants of concern |
Mutation
|
| 844 |
35454161 |
Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2 |
Mutation
|
| 845 |
35458530 |
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice |
Mutation
|
| 846 |
35467423 |
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy |
Mutation
|
| 847 |
35481766 |
Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant |
Mutation
|
| 848 |
35499994 |
Whole genome sequencing of SARS-CoV2 strains circulating in Iran during five waves of pandemic |
Mutation
|
| 849 |
32967693 |
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual |
Mutation
|
| 850 |
33013929 |
Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19 |
Mutation
|
| 851 |
33073198 |
Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2 |
Mutation
|
| 852 |
33105685 |
Viewpoint: Origin of SARS-CoV-2 |
Mutation
|
| 853 |
33163695 |
Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh |
Mutation
|
| 854 |
33344912 |
Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario |
Mutation
|
| 855 |
33357233 |
Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models |
Mutation
|
| 856 |
33506254 |
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis |
Mutation
|
| 857 |
34242876 |
Energetic and structural basis for the differences in infectivity between the wild-type and mutant spike proteins of SARS-CoV-2 in the Mexican population |
Mutation
|
| 858 |
34312429 |
S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study |
Mutation
|
| 859 |
34315847 |
N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding |
Mutation
|
| 860 |
34468954 |
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics |
Mutation
|
| 861 |
34526698 |
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis |
Mutation
|
| 862 |
34953513 |
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses |
Mutation
|
| 863 |
34959053 |
Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model |
Mutation
|
| 864 |
34962614 |
Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo |
Mutation
|
| 865 |
35062734 |
Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants |
Mutation
|
| 866 |
38684722 |
Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19 |
Mutation
|
| 867 |
38090396 |
Genomic Characterization of an Emerging SARS-CoV-2 Variant During the Early Second Wave of the SARS-CoV-2 Pandemic in Maharashtra, India |
Mutation
|
| 868 |
36635723 |
COVID-19: critical case of a patient with an atypical manifestation of the disease |
Mutation
|
| 869 |
36547242 |
Genomic Evidence Suggests Viral Persistence of SARS-CoV-2 for 386 Days in Health Worker: A Case Report from Santiago of Chile |
Mutation
|
| 870 |
36496300 |
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19 |
Mutation
|
| 871 |
36343703 |
Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic |
Mutation
|
| 872 |
36122486 |
Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays |
Mutation
|
| 873 |
32515358 |
Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility |
Mutation
|
| 874 |
32595352 |
An updated analysis of variations in SARS-CoV-2 genome |
Mutation
|
| 875 |
32595354 |
Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey |
Mutation
|
| 876 |
32879797 |
Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp |
Mutation
|
| 877 |
32943587 |
Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic |
Mutation
|
| 878 |
32950697 |
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America |
Mutation
|
| 879 |
33149541 |
New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release |
Mutation
|
| 880 |
33529260 |
Clinical and whole genome characterization of SARS-CoV-2 in India |
Mutation
|
| 881 |
34917639 |
Case Report: Genomic Characteristics of the First Known Case of SARS-CoV-2 Imported From Spain to Sichuan, China |
Mutation
|
| 882 |
39854608 |
Evolution of SARS-CoV-2 in white-tailed deer in Pennsylvania 2021-2024 |
Mutation
|
| 883 |
33496683 |
The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India |
Mutation
|
| 884 |
35314694 |
Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest |
Mutation
|
| 885 |
37083889 |
Wastewater surveillance of SARS-CoV-2 genomic populations on a country-wide scale through targeted sequencing |
Mutation
|
| 886 |
33433004 |
Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure |
Mutation
|
| 887 |
35482820 |
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms |
Mutation
|
| 888 |
32986807 |
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019 |
Mutation
|
| 889 |
34206274 |
Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type |
Mutation
|
| 890 |
35301314 |
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report |
Mutation
|
| 891 |
32967965 |
Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action |
Mutation
|
| 892 |
33225958 |
Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2 |
Mutation
|
| 893 |
36851165 |
Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs |
Mutation
|
| 894 |
38632523 |
Comprehensive genomic analysis of the SARS-CoV-2 Omicron variant BA.2.76 in Jining City, China, 2022 |
Mutation
|
| 895 |
38315011 |
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023 |
Mutation
|
| 896 |
38439047 |
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19 |
Mutation
|
| 897 |
32742818 |
RdRp mutations are associated with SARS-CoV-2 genome evolution |
Mutation
|
| 898 |
40362305 |
Impact of SARS-CoV-2 RBM Mutations N501Y and E484K on ACE2 Binding: A Combined Computational and Experimental Study |
Mutation
|
| 899 |
34400835 |
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution |
Mutation
|
| 900 |
39987216 |
The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dynamic features to enhance the interaction with the hACE2 |
Mutation
|
| 901 |
40020261 |
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity |
Mutation
|
| 902 |
34168071 |
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity |
Mutation
|
| 903 |
34572486 |
Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency |
Mutation
|
| 904 |
33275640 |
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody |
Mutation
|
| 905 |
36146826 |
Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2 |
Mutation
|
| 906 |
34547629 |
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2 |
Mutation
|
| 907 |
34998405 |
Different decay of antibody response and VOC sensitivity in naive and previously infected subjects at 15 weeks following vaccination with BNT162b2 |
Mutation
|
| 908 |
37235478 |
Shaping Nanobodies and Intrabodies against Proteoforms |
Mutation
|
| 909 |
37243201 |
Evaluation of Analytical and Clinical Performance and Usefulness in a Real-Life Hospital Setting of Two in-House Real-Time RT-PCR Assays to Track SARS-CoV-2 Variants of Concern |
Mutation
|
| 910 |
40213557 |
Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19 |
Mutation
|
| 911 |
33857422 |
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization |
Mutation
|
| 912 |
34074219 |
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro |
Mutation
|
| 913 |
34192529 |
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 |
Mutation
|
| 914 |
34220844 |
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom |
Mutation
|
| 915 |
34251356 |
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay |
Mutation
|
| 916 |
34379353 |
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies |
Mutation
|
| 917 |
34417349 |
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma |
Mutation
|
| 918 |
34580297 |
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 |
Mutation
|
| 919 |
34630410 |
A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants |
Mutation
|
| 920 |
34645933 |
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization |
Mutation
|
| 921 |
34787439 |
Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study |
Mutation
|
| 922 |
35008446 |
Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review |
Mutation
|
| 923 |
35032057 |
Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift |
Mutation
|
| 924 |
35115523 |
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater |
Mutation
|
| 925 |
35126106 |
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro |
Mutation
|
| 926 |
35173254 |
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants |
Mutation
|
| 927 |
35197985 |
Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19 |
Mutation
|
| 928 |
35215823 |
Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants |
Mutation
|
| 929 |
35279013 |
Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations |
Mutation
|
| 930 |
35505068 |
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants |
Mutation
|
| 931 |
35497518 |
Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant |
Mutation
|
| 932 |
33140034 |
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein |
Mutation
|
| 933 |
33893175 |
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice |
Mutation
|
| 934 |
34018203 |
Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin |
Mutation
|
| 935 |
34836485 |
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses |
Mutation
|
| 936 |
34087220 |
Synthetic proteins for COVID-19 diagnostics |
Mutation
|
| 937 |
36409737 |
Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding |
Mutation
|
| 938 |
32895623 |
Crystal structure of SARS-CoV-2 papain-like protease |
Mutation
|
| 939 |
34548835 |
Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies |
Mutation
|
| 940 |
37181765 |
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches |
Mutation
|
| 941 |
34234758 |
A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity |
Mutation
|
| 942 |
35343786 |
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8 |
Mutation
|
| 943 |
34305826 |
Introduction and Characteristics of SARS-CoV-2 in North-East of Romania During the First COVID-19 Outbreak |
Mutation
|
| 944 |
34729465 |
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells |
Mutation
|
| 945 |
33966351 |
Tracing genetic signatures of bat-to-human coronaviruses and early transmission of North American SARS-CoV-2 |
Mutation
|
| 946 |
33769311 |
IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity |
Mutation
|
| 947 |
38303011 |
Integrated approach for detection of SARS-CoV-2 and its variant by utilizing LAMP and ARMS-PCR |
Mutation
|
| 948 |
33090512 |
Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions |
Mutation
|
| 949 |
33350913 |
Territorywide Study of Early Coronavirus Disease Outbreak, Hong Kong, China |
Mutation
|
| 950 |
33815459 |
Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology |
Mutation
|
| 951 |
34030593 |
Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis |
Mutation
|
| 952 |
34188167 |
Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2 |
Mutation
|
| 953 |
34578142 |
Clinico-Genomic Analysis Reveals Mutations Associated with COVID-19 Disease Severity: Possible Modulation by RNA Structure |
Mutation
|
| 954 |
35126886 |
D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1 |
Mutation
|
| 955 |
40100755 |
A Phylogenetic Method Identifies Candidate Drivers of the Evolution of the SARS-CoV-2 Mutation Spectrum |
Mutation
|
| 956 |
33024144 |
Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020 |
Mutation
|
| 957 |
35252541 |
Optimizing peptide inhibitors of SARS-Cov-2 nsp10/nsp16 methyltransferase predicted through molecular simulation and machine learning |
Mutation
|
| 958 |
32779784 |
Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America |
Mutation
|
| 959 |
33945070 |
Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China |
Mutation
|
| 960 |
36156117 |
Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019 |
Mutation
|
| 961 |
32779445 |
Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients |
Mutation
|
| 962 |
32451533 |
Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases |
Mutation
|
| 963 |
39145418 |
Biochemical characterization of naturally occurring mutations in SARS-CoV-2 RNA-dependent RNA polymerase |
Mutation
|
| 964 |
34870573 |
SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity |
Mutation
|
| 965 |
34997207 |
SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1 |
Mutation
|
| 966 |
38483913 |
Unravelling the link between SARS-CoV-2 mutation frequencies, patient comorbidities, and structural dynamics |
Mutation
|
| 967 |
34876891 |
Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies |
Mutation
|
| 968 |
33797663 |
Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics |
Mutation
|
| 969 |
38028396 |
Novel Mutations in the Non-Structure Protein 2 of SARS-CoV-2 |
Mutation
|
| 970 |
36811085 |
Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene |
Mutation
|
| 971 |
35743837 |
Identifying COVID-19 Severity-Related SARS-CoV-2 Mutation Using a Machine Learning Method |
Mutation
|
| 972 |
34011679 |
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers |
Mutation
|
| 973 |
32904401 |
BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission |
Mutation
|
| 974 |
32980406 |
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) |
Mutation
|
| 975 |
34534263 |
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2 |
Mutation
|
| 976 |
34663909 |
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation |
Mutation
|
| 977 |
37466213 |
Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) |
Mutation
|
| 978 |
35569431 |
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant |
Mutation
|
| 979 |
37872472 |
Nucleocapsid single point-mutation associated with drop-out on RT-PCR assay for SARS-CoV-2 detection |
Mutation
|
| 980 |
35075180 |
Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk |
Mutation
|
| 981 |
35386683 |
SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key |
Mutation
|
| 982 |
35454022 |
Unusual N Gene Dropout and Ct Value Shift in Commercial Multiplex PCR Assays Caused by Mutated SARS-CoV-2 Strain |
Mutation
|
| 983 |
39990941 |
Exploring Possible Drug-Resistant Variants of SARS-CoV-2 Main Protease (M(pro)) with Noncovalent Preclinical Candidate, Mpro61 |
Mutation
|
| 984 |
36775130 |
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease |
Mutation
|
| 985 |
37271339 |
Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors |
Mutation
|
| 986 |
39712205 |
An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV-2 M(pro) |
Mutation
|
| 987 |
39893201 |
Distal protein-protein interactions contribute to nirmatrelvir resistance |
Mutation
|
| 988 |
40133408 |
Inhibitory efficacy and structural insights of Bofutrelvir against SARS-CoV-2 M(pro) mutants and MERS-CoV M(pro) |
Mutation
|
| 989 |
40183562 |
Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50 |
Mutation
|
| 990 |
33649700 |
Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19 |
Mutation
|
| 991 |
32984400 |
Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M(pro) Protease Target Host Selenoproteins and Glutathione Synthesis? |
Mutation
|
| 992 |
34399606 |
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 |
Mutation
|
| 993 |
33894500 |
Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants |
Mutation
|
| 994 |
32816316 |
Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase |
Mutation
|
| 995 |
34938188 |
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery |
Mutation
|
| 996 |
33705994 |
A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics |
Mutation
|
| 997 |
33385461 |
Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study |
Mutation
|
| 998 |
38058248 |
A naturally occurring G11S mutation in the 3C-like protease from the SARS-CoV-2 virus dramatically weakens the dimer interface |
Mutation
|
| 999 |
37191515 |
Rapid Detection of Predominant SARS-CoV-2 Variants Using Multiplex High-Resolution Melting Analysis |
Mutation
|
| 1000 |
34835288 |
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine |
Mutation
|
| 1001 |
39862805 |
Topologically constrained DNA-mediated one-pot CRISPR assay for rapid detection of viral RNA with single nucleotide resolution |
Mutation
|
| 1002 |
34248221 |
Viral transmission and evolution dynamics of SARS-CoV-2 in shipboard quarantine |
Mutation
|
| 1003 |
34039497 |
An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose |
Mutation
|
| 1004 |
34545191 |
Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters |
Mutation
|
| 1005 |
35115239 |
Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report |
Mutation
|
| 1006 |
35129839 |
Vaccination of COVID-19 convalescent plasma donors increases binding and neutralizing antibodies against SARS-CoV-2 variants |
Mutation
|
| 1007 |
35544862 |
First report and genome sequencing of SARS-CoV-2 in a cat (Felis catus) in Colombia |
Mutation
|
| 1008 |
35707790 |
Pitfalls of PCR-RFLP in Detecting SARS-CoV-2 D614G Mutation |
Mutation
|
| 1009 |
35747326 |
Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus |
Mutation
|
| 1010 |
36034515 |
Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemic |
Mutation
|
| 1011 |
34197265 |
Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters |
Mutation
|
| 1012 |
34858404 |
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine |
Mutation
|
| 1013 |
34786352 |
Gasless laparoendoscopic single-site surgery for management of unruptured tubal pregnancy in a woman with moderate COVID-19 pneumonia after administration of remdesivir and casirivimab-imdevimab: A case report |
Mutation
|
| 1014 |
35855062 |
A low proportion of asymptomatic COVID-19 patients with the Delta variant infection by viral transmission through household contact at the time of confirmation in Ibaraki, Japan |
Mutation
|
| 1015 |
38902563 |
Assessing Excess Mortality of Baby Boomers from the COVID-19 Pandemic: Taiwan Omicron-naive Cohort |
Mutation
|
| 1016 |
39640263 |
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity |
Mutation
|
| 1017 |
33918060 |
Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2 |
Mutation
|
| 1018 |
34278371 |
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany |
Mutation
|
| 1019 |
34358019 |
Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants |
Mutation
|
| 1020 |
34385423 |
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo |
Mutation
|
| 1021 |
34416193 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial |
Mutation
|
| 1022 |
34417165 |
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study |
Mutation
|
| 1023 |
34471122 |
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques |
Mutation
|
| 1024 |
34620109 |
Real-time quantification of the transmission advantage associated with a single mutation in pathogen genomes: a case study on the D614G substitution of SARS-CoV-2 |
Mutation
|
| 1025 |
34829998 |
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape |
Mutation
|
| 1026 |
34914688 |
Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant |
Mutation
|
| 1027 |
34945159 |
Clinical Characteristics of Patients with SARS-CoV-2 N501Y Variants in General Practitioner Clinic in Japan |
Mutation
|
| 1028 |
35013591 |
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California |
Mutation
|
| 1029 |
35060426 |
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents |
Mutation
|
| 1030 |
35165301 |
Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan |
Mutation
|
| 1031 |
35215911 |
Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells |
Mutation
|
| 1032 |
35236358 |
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant |
Mutation
|
| 1033 |
35281007 |
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections |
Mutation
|
| 1034 |
35497643 |
The twin-beginnings of COVID-19 in Asia and Europe-one prevails quickly |
Mutation
|
| 1035 |
32870641 |
Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences |
Mutation
|
| 1036 |
32935498 |
Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders |
Mutation
|
| 1037 |
33335187 |
CoV2-ID, a MIQE-compliant sub-20-min 5-plex RT-PCR assay targeting SARS-CoV-2 for the diagnosis of COVID-19 |
Mutation
|
| 1038 |
33786200 |
Global Evidence of Temperature Acclimation of COVID-19 D614G Linage |
Mutation
|
| 1039 |
33851216 |
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019 |
Mutation
|
| 1040 |
34059617 |
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity |
Mutation
|
| 1041 |
34073577 |
Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays |
Mutation
|
| 1042 |
34120577 |
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination |
Mutation
|
| 1043 |
33804556 |
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations |
Mutation
|
| 1044 |
34129831 |
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening |
Mutation
|
| 1045 |
34335010 |
Double masking protection vs. comfort-A quantitative assessment |
Mutation
|
| 1046 |
34384810 |
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? |
Mutation
|
| 1047 |
34561414 |
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients |
Mutation
|
| 1048 |
34624095 |
The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants |
Mutation
|
| 1049 |
35345417 |
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study |
Mutation
|
| 1050 |
35597120 |
Immunoinformatic paradigm predicts macrophage and T-cells epitope responses against globally conserved spike fragments of SARS CoV-2 for universal vaccination |
Mutation
|
| 1051 |
33166683 |
Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2 |
Mutation
|
| 1052 |
35914217 |
SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case |
Mutation
|
| 1053 |
40305276 |
Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study |
Mutation
|
| 1054 |
36075211 |
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice |
Mutation
|
| 1055 |
36916974 |
Transmission of SARS-CoV-2 Omicron Variant under a Dynamic Clearance Strategy in Shandong, China |
Mutation
|